| 产品详情 |
| Edit |   |
|---|
| Product Name | BML-259 |
|---|
| Description | MW: 260.4. Purity >98% (TLC: 5% CH3OH/CH2Cl2; Rf=0.46); NMR (Conforms). CDK5/p25 inhibitorScientific Background: Potent inhibitor of CDK5/p25 (IC50=64 nM). Inhibits CDK2/cyclin E at slightly higher concentration (IC50=98nM) (1). Protects cells against NAC-amyloid-induced cell death (2). Cell permeable. |
|---|
| Size | 5 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [GW2580; N-(5-Isopropylthiazol-2-yl) phenylacetamide ] |
|---|
| Gene, Accession, CAS # | CAS: 267654-00-2 |
|---|
| Catalog # | MBS515058 |
|---|
| Price | |
|---|
| Order / More Info | BML-259 from MYBIOSOURCE INC. |
|---|
| Product Specific References | 1. CJ Helal et al. Bioorg. Med. Chem. Lett. 2004 14:5521 2. A Kazmierczak et al. Neurochem. Int. 2011 58:206 |
|---|
| 产品资料 |
|
|